Dr. Maude is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104Phone(215) 590-3535
Fax(215) 590-3992- Is this information wrong?
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2009 - 2012
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
PA State Medical License 2006 - 2022- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL Shannon Maude, MD, PhD
Publications & Presentations
PubMed
- 1 citationsRisk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical ...Stephan Kadauke, Regina M Myers, Yimei Li, Richard Aplenc, Diane Baniewicz, David M. Barrett, Allison Barz Leahy, Colleen Callahan, Joseph G Dolan, Julie C. Fitzgerald...> ;Journal of Clinical Oncology. 2021 Jan 8
- What is the role for HSCT or immunotherapy in pediatric hypodiploid B-cell acute lymphoblastic leukemia?Aimee C Talleur, Shannon L. Maude> ;Hematology. 2020 Dec 4
- CAR T cells vs allogeneic HSCT for poor-risk ALL.Caroline Diorio, Shannon L. Maude> ;Hematology. 2020 Dec 4
- Join now to see all
Abstracts/Posters
- Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell TherapyShannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019Shannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell EfficacyShannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Integrating CAR T-Cell Therapy Into the Treatment of Lymphoma, Myeloma, and Leukemia: Strategies for Maximizing Patient Outcomes60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
CAR T-cell Therapy Hailed as Transformative in Pediatric MedicineDecember 20th, 2018
The Future of Immunotherapy, CAR-T and BeyondNovember 22nd, 2018- 2018 POGO Symposium on Childhood CancerNovember 22nd, 2018
- Join now to see all
Hospital Affiliations
Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
